Scharf Writes for FDLI on Proposed Revision to FDA Rules

Partner Stephanie Scharf has published an article for the March/April issue of Update, the journal of the Food and Drug Law Institute, entitled, “FDA Proposes Revised CBE Rules and Reiterates Preemptive Authority.” To see a copy of the article, click here.